|
|
|
|
|
21.08.25 - 10:36
|
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea® (GlobeNewswire EN)
|
|
|
REYKJAVIK, Iceland and LONDON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Commission has approved Mynzepli® as a biosimilar to Eylea® (aflibercept), in a pre-filled syringe and vial....
|
|
|
|
|
20.08.25 - 01:45
|
Auna S.A. (AUNA) Beats Q2 Earnings Estimates (Zacks)
|
|
|
Auna S.A. (AUNA) delivered earnings and revenue surprises of +153.85% and -3.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...
|
|
|
|
|
19.08.25 - 22:18
|
Auna Announces 2Q25 Financial Results (Business Wire)
|
|
|
Adjusted EBITDA increases 5% FXN YoY with all segments contributing positively to quarterly results in their local currencyLUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the second quarter ended June 30, 2025 (“second quarter 2025” or “2Q25”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted.
2Q25 Consolidated Highlights
Consolidated Revenue increased 4% FXN while decreasing 2% YoY on reported basis to S/1,094 million
Adjusted EBITDA increased 5% FXN, and decreased 3% YoY to S/241 million
Adjusted EBITDA Margin remained flat at 22.1%
Adjusted Net Income was S/89 million, up from S/13 million in 2Q24 and S/55 million in 1Q25
Leverage Ratio was 3.6x, in line with 3.6x in 1Q25
Oncology MLR reached a...
|
|
|
|
|
|
|
|
|
13.08.25 - 22:18
|
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update (GlobeNewswire EN)
|
|
|
REYKJAVIK, Iceland, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for the first six months of 2025 and provided a summary of recent pipeline and corporate highlights. Management will conduct a business update conference call and live webcast on August 14, 2025, at 8:00 am ET (12:00 pm GMT)....
|
|
|
13.08.25 - 22:18
|
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update (GlobeNewswire EN)
|
|
|
REYKJAVIK, Iceland, August 13, 2025 - Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for the first six months of 2025 and provided a summary of recent pipeline and corporate highlights. Management will conduct a business update conference call and live webcast on August 14, 2025, at 8:00 am ET (12:00 pm GMT)....
|
|
|
|
|
13.08.25 - 06:09
|
TAGESVORSCHAU: Termine am 13. August 2025 (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine am Mittwoch, den 13. August 2025^TERMINE UNTERNEHMEN06:30 DEU: Formycon, Halbjahreszahlen (15.00 h Call)06:50 LUX: Grand City Properties, Halbjahreszahlen07:00 DEU: ......
|
|
|
12.08.25 - 17:39
|
TAGESVORSCHAU: Termine am 13. August 2025 (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine am Mittwoch, den 13. August 2025^TERMINE UNTERNEHMEN06:30 DEU: Formycon, Halbjahreszahlen (15.00 h Call)06:50 LUX: Grand City Properties, Halbjahreszahlen07:00 DEU: ......
|
|
|
|
|
08.08.25 - 09:18
|
DAX hofft auf Frieden – Bechtle, Deutz, Eckert & Ziegler, Heidelberg Materials, Jungheinrich, Munich Re, Rheinmetall, RTL Group im Check (Der Aktionaer)
|
|
|
Die Aussicht auf Frieden in Europa hat dem DAX am Donnerstag zeitweise ein Plus von knapp 500 Zählern beschert. Die Gewinne konnten jedoch bis zum Handelsende nicht verteidigt werden, so dass der deutsche Leitindex 1,12 Prozent oder 268 Punkte höher, aber immer noch deutlich oberhalb der 24....
|
|
|
06.08.25 - 14:06
|
Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT (GlobeNewswire EN)
|
|
|
REYKJAVIK, ICELAND (August 6, 2025) – Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first half of the year ended June 30, 2025, after U.S. markets close on Wednesday, August 13, 2025. Alvotech will also conduct a conference call to present the financial results and recent business highlights on Thursday August 14, 2025, at 8:00 am EDT (12:00 noon GMT, 14:00 CET). Live audio of the conference call will be webcast and available on Alvotech's investor portal....
|
|
|
05.08.25 - 19:12
|
Börsenradio Schlussbericht, Di., 05. August 2025 - Turnaround Thursday: die Stimmung hebt sich. - Heiko Thieme (BRN)
|
|
|
Der "Turnaround Thursday" macht seinem Namen alle Ehre. Zinshoffnungen und starke Quartalszahlen geben den Märkten Rückenwind. Der DAX schließt +0,4 % höher bei 23.857 Punkten, der Euro-Stoxx-50 gewinnt +0,1 %. Aus dem DAX überzeugt Infineon, während Fresenius Medical Care nach Zahlen leicht nachgibt. Commerzbank-Aktien verlieren vor den morgigen Zahlen -6,2 % auf 31,34 Euro. Der ISM-Service-Index aus den USA enttäuscht mit 50,1 Punkten - Zinssenkungsfantasien leben wieder auf. DHL steigert das Ebit um 6 % auf 1,4 Mrd. Euro, trotz Umsatzrückgang auf 19,8 Mrd. Euro. FMC verdient 476 Mio. Euro, Infineon 305 Mio. Euro (−24 %). Fraport verbessert das Ergebnis auf 384 Mio. Euro, bei leichtem Umsatzrückgang. Palantir springt nach starken Zahlen +7,5 %, Pfizer hebt die Prognose an. DuPont profitiert vom KI-Boom, Hugo Boss steigert das Ebit um 15 %. Der deutsche Automarkt legt zu, Tesla verliert Marktanteile. Spotify dreht erneut an der Preisschraube, Saudi Aramco meldet -22 % Gewinnrückgang. ...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
